Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13
Policy
Policy | 03 August 2021

PLI Scheme to generate export potential of Rs 196,000 crore by 2027 : Mandaviya

The scheme incentivizes the manufacturing of patented drugs and other high value drugs at an incentive rate of 10% of incremental sales

Policy
Policy | 03 August 2021

NPPA monitors and caps prices of essential drugs: Mandaviya

NPPA has capped the trade margin for Oxygen Concentrators at 70% on Price to Distributor (PTD) level

Policy
Policy | 03 August 2021

NPPA caps prices on five medical devices effective July 20th 2021

The highest reduction in prices for Pulse Oximeters, Blood Pressure Monitoring Machine and Nebulizer has been reported by importers

Policy
Policy | 03 August 2021

API exports surpass imports by value in 2020-21

The govt has rolled out three schemes for promoting the manufacture of API

Policy
Policy | 03 August 2021

Drug exports grow on the back of govt support

Drug formulations and biologics make impressive gains

Policy
Policy | 28 July 2021

Hugely successful vaccination roll out made possible by India-UK partnership

The contribution of Wockhardt at Wrexham is one of the best examples of the success and significant potential of India-UK partnerships in the healthcare sector

Policy
Policy | 03 June 2021

Zydus Cadila receives tentative approval from USFDA for lung cancer drugs

Osimertinib works by slowing or stopping the growth of cancer cells and binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors

Policy
Policy | 29 May 2021

Shilpa Medicare Jadcherla facility gets GMP certification from Russia

The GMP certificate is valid for three years until April 2024.

Policy
Policy | 27 May 2021

Zydus seeks DCGI approval for monoclonal antibodies cocktail

Cocktails of 2 mAbs based products are better equipped to deal with variants than single mAb based products which have a tendency of losing their efficacy with rapidly generating variants

Policy
Policy | 25 May 2021

Cipla to market Roche's Antibody Cocktail in India

The antibody cocktail is to be administered for the treatment of mild to moderate COVID-19

Policy
Policy | 24 May 2021

NATCO Pharma receives USFDA approval for Lenalidomide capsules

NATCO and Arrow shall launch the product on agreed-upon launch dates in the future.

Policy
Policy | 10 May 2021

DCGI approves anti-COVID drug developed by DRDO

The drug accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production

Policy
Policy | 20 April 2021

Indian pharma industry registers 18% exports growth: Narendra Modi

Essential medicines were made available to more than 150 countries around the world during the pandemic

Policy
Policy | 14 April 2021

Pharma PLI to increase exports

Indian government is expecting pharmaceutical industry to fetch incremental sales worth Rs. 294,000 crore and exports up to Rs. 196,000 crore by FY 2027-28

Policy
Policy | 09 April 2021

Pharma sector has both brainpower and manpower to drive growth: Mandaviya

The government has taken all the effective measures to make healthcare affordable

Policy
Policy | 15 January 2021

Pan-India COVID-19 vaccination drive to cover 300,000 persons per day

This vaccination programme is based on the principles of priority groups to be vaccinated and health care workers both in the government and private sectors including ICDS workers will receive the vaccine during this phase.

Policy
Policy | 13 January 2021

LASA receives WHO nod for its Ratnagiri unit

Lasa Supergenerics Limited has received WHO GMP Certificate for its manufacturing facility situated at Khed in Ratnagiri.

Policy
Policy | 11 January 2021

States need to capture vaccination data: R. S. Sharma

Their feedback and the consequent changes in software/protocols based on those inputs were deliberated upon.

Startup

Digitization